CHLA participates in novel cancer consortium announced at the Biden Cancer Summit
Share

IMAGE: Lee Helman, M.D., head of Basic and Translational Research within the Children’s Center for Cancer and Blood Diseases at Children’s Hospital Los Angeles, is a founding member of the newly… view more 

Credit: Photo courtesy of CHLA

Former Vice President Joe Biden and Dr. Jill Biden hosted the national Biden Cancer Summit, on Sept. 21, to highlight the urgent need for creating transformative approaches to cancer prevention, research and treatment. One of the new initiatives announced was the formation of a consortium to advance research into effective treatments for patients with a type of cancer called Gastrointestinal Stromal Tumor (GIST) who do not respond to current standard treatments.

Lee Helman, MD, head of Basic and Translational Research within the Children’s Center for Cancer and Blood Diseases at Children’s Hospital Los Angeles, is a founding member of the newly formed, Pediatric and SDH-Deficient GIST Consortium. In 2008, Helman was responsible for the initiation of the first clinic devoted to pediatric patients with “wild-type GIST” who did not benefit from the treatment that had recently been found effective for most adult GIST patients. The vast majority of the patients who did not respond to treatment were determined to have a

read more...


Article originally posted at
www.eurekalert.org

Click here for the full story


CategoryAggregator News

© 2017 - LIFE EXTENSION ADVOCACY FOUNDATION
Privacy Policy / Terms Of Use

Powered by MMD